Isolating circulating tumor cells (CTCs) in the blood was a
major breakthrough in cancer detection. As researchers learn more about the
potential clinical applications of measuring and characterizing these new cancer
biomarkers, they are also learning more about how the technologies being used to
measure CTCs will impact labs in the future. Attend this webinar to learn about
the latest developments in this fascinating new area of laboratory medicine.